Nitric Oxide Synthase
From Proteopedia
(Difference between revisions)
Line 92: | Line 92: | ||
Structures used in the section above: [[1tll]] | Structures used in the section above: [[1tll]] | ||
+ | |||
+ | == 3D Structures of Nitric Oxide Synthase == | ||
+ | [[Nitric Oxide Synthase 3D structures]] | ||
+ | |||
</StructureSection> | </StructureSection> | ||
== 3D Structures of Nitric Oxide Synthase == | == 3D Structures of Nitric Oxide Synthase == | ||
Line 100: | Line 104: | ||
*Endothelial NOS | *Endothelial NOS | ||
+ | **[[3eah]] – h-eNOS OD - human<br /> | ||
+ | **[[3nos]], [[4d1o]] – h-eNOS OD+arginine<br /> | ||
+ | **[[1m9j]] – h-eNOS OD+chlorzoxazone<br /> | ||
+ | **[[1m9k]], [[1m9r]], [[4d1p]], [[6av7]], [[6av6]], [[6nhf]], [[6nh8]], [[6nh7]], [[6nh6]], [[6nh5]], [[6nh4]], [[6nh3]], [[6nh2]], [[6nh1]], [[6cif]], [[6cie]] – h-eNOS OD+ inhibitor<br /> | ||
+ | **[[1nsi]] - h-eNOS OD+ Zn<br /> | ||
**[[3nld]], [[3nle]], [[3nlf]], [[3nlg]], [[3jww]], [[3jwx]], [[3jwy]], [[3jwz]], [[3dqs]], [[3dqt]], [[3pnh]], [[4luw]] – b-eNOS OD+pyrrolidinomethyl pyridine derivative – bovine<br /> | **[[3nld]], [[3nle]], [[3nlf]], [[3nlg]], [[3jww]], [[3jwx]], [[3jwy]], [[3jwz]], [[3dqs]], [[3dqt]], [[3pnh]], [[4luw]] – b-eNOS OD+pyrrolidinomethyl pyridine derivative – bovine<br /> | ||
**[[1dm6]] – b-eNOS OD+guanidine derivative<br /> | **[[1dm6]] – b-eNOS OD+guanidine derivative<br /> | ||
Line 121: | Line 130: | ||
**[[4jsk]], [[4jsl]], [[4jsm]], [[4imx]], [[4k5h]], [[4k5i]], [[4k5j]], [[4k5k]], [[4c3a]] – r-eNOS OD+ pyridine derivative<br /> | **[[4jsk]], [[4jsl]], [[4jsm]], [[4imx]], [[4k5h]], [[4k5i]], [[4k5j]], [[4k5k]], [[4c3a]] – r-eNOS OD+ pyridine derivative<br /> | ||
**[[4kcp]], [[4kcq]], [[4kcr]], [[4kcs]] - r-eNOS OD heme domain +thiophene carboximidamide derivative<br /> | **[[4kcp]], [[4kcq]], [[4kcr]], [[4kcs]] - r-eNOS OD heme domain +thiophene carboximidamide derivative<br /> | ||
- | **[[3eah]] – h-eNOS OD - human<br /> | ||
- | **[[3nos]], [[4d1o]] – h-eNOS OD+arginine<br /> | ||
- | **[[1m9j]] – h-eNOS OD+chlorzoxazone<br /> | ||
- | **[[1m9k]], [[1m9r]], [[4d1p]], [[6av7]], [[6av6]] – h-eNOS OD+ inhibitor<br /> | ||
- | **[[1nsi]] - h-eNOS OD+ Zn | ||
*Neuronal NOS | *Neuronal NOS | ||
+ | **[[4uh5]], [[6av5]], [[6av4]], [[6av3]] - h-nNOS heme domain +inhibitor<br /> | ||
+ | **[[4uh6]], [[4uch]], [[6av2]], [[6av1]], [[6av0]], [[6auz]], [[6auy]], [[5vv4]], [[5vv2]], [[5vv1]], [[5vuz]], [[5vuy]], [[5vux]], [[5vuw]], [[5vuv]], [[6nhb]], [[6nhc]], [[6cid]], [[6ng8]], [[6ngi]], [[6ngh]], [[6ngf]], [[6nge]], [[6ngd]], [[6ngc]], [[6ngb]], [[6nga]], [[6ng7]], [[6ng6]], [[6ng5]], [[6ng4]], [[6ng2]], [[6ng1]], [[6cic]] - h-nNOS heme domain + inhibitor<br /> | ||
+ | **[[4d1n]] - h-nNOS heme domain (mutant) + arginine<br /> | ||
**[[2hx2]] – b-nNOS OD+nitroguanidine derivative<br /> | **[[2hx2]] – b-nNOS OD+nitroguanidine derivative<br /> | ||
**[[3nlv]], [[3nlw]], [[3nlx]], [[3nly]], [[3nlz]], [[3nm0]], [[4uh7]], [[4uh8]], [[4uh9]], [[4uha]] - b-nNOS OD + inhibitor<br /> | **[[3nlv]], [[3nlw]], [[3nlx]], [[3nly]], [[3nlz]], [[3nm0]], [[4uh7]], [[4uh8]], [[4uh9]], [[4uha]] - b-nNOS OD + inhibitor<br /> | ||
Line 143: | Line 150: | ||
**[[1qau]] - r-nNOS OD PDZ domain<br /> | **[[1qau]] - r-nNOS OD PDZ domain<br /> | ||
**[[1qav]], [[4hop]] - r-nNOS OD PDZ domain + α-1 syntrophin<br /> | **[[1qav]], [[4hop]] - r-nNOS OD PDZ domain + α-1 syntrophin<br /> | ||
- | **[[1qwc]], [[3q99]], [[3q9a]], [[1mmv]], [[1mmw]], [[3dqr]], [[3ufo]], [[3ufp]], [[3ufq]], [[3ufr]], [[3ufs]], [[3uft]], [[3ufu]], [[3ufv]], [[3ufw]], [[4eux]], [[5vui]], [[4upm]], [[4upn]], [[4upo]], [[4upp]], [[5vuk]], [[5vul]], [[5vum]], [[5vun]], [[5vuo]], [[5vup]], [[5vuq]], [[5vur]], [[5vus]], [[5vut]], [[5vuu]], [[5unr]], [[5unt]], [[5unu]], [[5unv]], [[5unw]], [[5unx]], [[5uny]], [[5unz]], [[5uo0]], [[5fw0]], [[5fvo]], [[5fvp]], [[5fvq]], [[5fvr]], [[5fvs]], [[5fvt]], [[5agk]], [[5agl]], [[5agm]], [[5agn]], [[5ago]], [[5agp]], [[4v3v]], [[4v3w]], [[4v3x]], [[4v3y]], [[4v3z]], [[5ad4]], [[5ad5]], [[5ad6]], [[5ad7]], [[5ad8]], [[5ad9]], [[5ada]], [[5adb]], [[5adc]], [[4ugz]], [[4d33]], [[4d34]], [[4d35]], [[4d2y]], [[4d1z]], [[4d30]], [[4d31]], [[4uh4]], [[4d7o]], [[4d3b]], [[4d32]], [[4ctp]], [[4ctq]], [[4ctr]], [[4ctt]], [[4ctu]], [[4ctv]], [[4c39]], [[6aux]], [[6auw]], [[6auv]], [[6auu]], [[6aut]], [[6aur]], [[6auq]], [[5vuj]], [[4uh3]], [[4uh2]], [[4uh1]], [[4uh0]], [[4d2z]], [[4ctx]], [[4ctw]] – r-nNOS OD+inhibitor<br /> | + | **[[1qwc]], [[3q99]], [[3q9a]], [[1mmv]], [[1mmw]], [[3dqr]], [[3ufo]], [[3ufp]], [[3ufq]], [[3ufr]], [[3ufs]], [[3uft]], [[3ufu]], [[3ufv]], [[3ufw]], [[4eux]], [[5vui]], [[4upm]], [[4upn]], [[4upo]], [[4upp]], [[5vuk]], [[5vul]], [[5vum]], [[5vun]], [[5vuo]], [[5vup]], [[5vuq]], [[5vur]], [[5vus]], [[5vut]], [[5vuu]], [[5unr]], [[5unt]], [[5unu]], [[5unv]], [[5unw]], [[5unx]], [[5uny]], [[5unz]], [[5uo0]], [[5fw0]], [[5fvo]], [[5fvp]], [[5fvq]], [[5fvr]], [[5fvs]], [[5fvt]], [[5agk]], [[5agl]], [[5agm]], [[5agn]], [[5ago]], [[5agp]], [[4v3v]], [[4v3w]], [[4v3x]], [[4v3y]], [[4v3z]], [[5ad4]], [[5ad5]], [[5ad6]], [[5ad7]], [[5ad8]], [[5ad9]], [[5ada]], [[5adb]], [[5adc]], [[4ugz]], [[4d33]], [[4d34]], [[4d35]], [[4d2y]], [[4d1z]], [[4d30]], [[4d31]], [[4uh4]], [[4d7o]], [[4d3b]], [[4d32]], [[4ctp]], [[4ctq]], [[4ctr]], [[4ctt]], [[4ctu]], [[4ctv]], [[4c39]], [[6aux]], [[6auw]], [[6auv]], [[6auu]], [[6aut]], [[6aur]], [[6auq]], [[5vuj]], [[4uh3]], [[4uh2]], [[4uh1]], [[4uh0]], [[4d2z]], [[4ctx]], [[4ctw]], [[6nhe]], [[6nhd]], [[6nh0]], [[6ngz]], [[6ngy]], [[6ngx]], [[6ngw]], [[6ngv]], [[6ngu]], [[6ngt]], [[6ngs]], [[6ngr]], [[6ngq]], [[6ngp]], [[6ngn]], [[6ngm]], [[6ngl]], [[6ngk]], [[6ngj]] – r-nNOS OD+inhibitor<br /> |
**[[5vv0]], [[5vv3]], [[5vv5]], [[5uns]], [[5uo1]], [[5uo2]], [[5uo3]], [[5uo4]], [[5uo5]], [[5uo6]], [[5uo7]], [[5g0n]], [[5g0p]], [[5fvu]], [[5fvv]], [[5fvx]], [[5fvw]], [[5fvx]], [[4v3u]], [[5add]], [[5ade]], [[5adf]], [[5adg]], [[5adi]], [[4cx3]], [[4cx4]], [[4cx5]], [[4cx6]], [[6aus]], [[5g0o]] – r-nNOS OD (mutant) +inhibitor<br /> | **[[5vv0]], [[5vv3]], [[5vv5]], [[5uns]], [[5uo1]], [[5uo2]], [[5uo3]], [[5uo4]], [[5uo5]], [[5uo6]], [[5uo7]], [[5g0n]], [[5g0p]], [[5fvu]], [[5fvv]], [[5fvx]], [[5fvw]], [[5fvx]], [[4v3u]], [[5add]], [[5ade]], [[5adf]], [[5adg]], [[5adi]], [[4cx3]], [[4cx4]], [[4cx5]], [[4cx6]], [[6aus]], [[5g0o]] – r-nNOS OD (mutant) +inhibitor<br /> | ||
**[[3jt3]], [[3jt4]], [[3jt5]], [[3jt6]], [[3jt7]], [[3jt8]], [[3jt9]], [[3jta]] – r-nNOS OD+ornithine derivative<br /> | **[[3jt3]], [[3jt4]], [[3jt5]], [[3jt6]], [[3jt7]], [[3jt8]], [[3jt9]], [[3jta]] – r-nNOS OD+ornithine derivative<br /> | ||
Line 156: | Line 163: | ||
**[[1f20]] - r-nNOS FAD/NADP domain<br /> | **[[1f20]] - r-nNOS FAD/NADP domain<br /> | ||
**[[1vag]] – m-nNOS OD+inhibitor - mouse<br /> | **[[1vag]] – m-nNOS OD+inhibitor - mouse<br /> | ||
- | **[[4uh5]], [[6av5]], [[6av4]] - h-nNOS heme domain +inhibitor<br /> | ||
- | **[[4uh6]], [[4uch]], [[6av2]], [[6av1]], [[6av0]], [[6auz]], [[6auy]], [[5vv4]], [[5vv2]], [[5vv1]], [[5vuz]], [[5vuy]], [[5vux]], [[5vuw]], [[5vuv]] - h-nNOS heme domain + inhibitor<br /> | ||
- | **[[4d1n]] - h-nNOS heme domain (mutant) + arginine<br /> | ||
*Inducible NOS | *Inducible NOS | ||
+ | **[[3hr4]] – h-iNOS residues 503-715+calmodulin <br /> | ||
+ | **[[3e7g]] – h-iNOS residues 82-505+inhibitor<br /> | ||
+ | **[[3ej8]] – h-iNOS OD+imidazole<br /> | ||
+ | **[[4nos]], [[4cx7]] – h-iNOS OD+inhibitor<br /> | ||
+ | **[[1nsi]] – h-iNOS OD+arginine<br /> | ||
+ | **[[2nsi]] – h-iNOS OD+thiourea derivative<br /> | ||
**[[3nqs]], [[3e65]], [[3eai]], [[3ebd]], [[3ebf]], [[1r35]], [[2nod]] – m-iNOS OD + pterin derivative<br /> | **[[3nqs]], [[3e65]], [[3eai]], [[3ebd]], [[3ebf]], [[1r35]], [[2nod]] – m-iNOS OD + pterin derivative<br /> | ||
**[[1jwj]], [[1jwk]] – m-iNOS OD (mutant)+ pterin derivative<br /> | **[[1jwj]], [[1jwk]] – m-iNOS OD (mutant)+ pterin derivative<br /> | ||
Line 182: | Line 192: | ||
**[[1jwj]] – m-iNOS OD + inhibitor<br /> | **[[1jwj]] – m-iNOS OD + inhibitor<br /> | ||
**[[1jwk]] - m-iNOS OD (mutant) + inhibitor<br /> | **[[1jwk]] - m-iNOS OD (mutant) + inhibitor<br /> | ||
- | **[[3hr4]] – h-iNOS residues 503-715+calmodulin – human<br /> | ||
- | **[[3e7g]] – h-iNOS residues 82-505+inhibitor<br /> | ||
- | **[[3ej8]] – h-iNOS OD+imidazole<br /> | ||
- | **[[4nos]], [[4cx7]] – h-iNOS OD+inhibitor<br /> | ||
- | **[[1nsi]] – h-iNOS OD+arginine<br /> | ||
- | **[[2nsi]] – h-iNOS OD+thiourea derivative<br /> | ||
**[[3gof]] - c-iNOS OD + calmodulin – chicken<br /> | **[[3gof]] - c-iNOS OD + calmodulin – chicken<br /> | ||
Revision as of 10:12, 10 November 2019
|
3D Structures of Nitric Oxide Synthase
Updated on 10-November-2019
References
- ↑ Flemming, I., Chapter 3, Biology of Nitric Oxide Synthases, from Microcirculation, Editors Ronald F. Tuma, R. F., Durán, W. N., and Ley, K., 2nd edition, Academic Press, 2008
- ↑ Gorren AC, Mayer B. Nitric-oxide synthase: a cytochrome P450 family foster child. Biochim Biophys Acta. 2007 Mar;1770(3):432-45. Epub 2006 Sep 1. PMID:17014963 doi:10.1016/j.bbagen.2006.08.019
- ↑ Fan B, Wang J, Stuehr DJ, Rousseau DL. NO synthase isozymes have distinct substrate binding sites. Biochemistry. 1997 Oct 21;36(42):12660-5. PMID:9376373 doi:http://dx.doi.org/10.1021/bi9715369
- ↑ Rousseau DL, Li D, Couture M, Yeh SR. Ligand-protein interactions in nitric oxide synthase. J Inorg Biochem. 2005 Jan;99(1):306-23. PMID:15598509 doi:http://dx.doi.org/10.1016/j.jinorgbio.2004.11.007
- ↑ 5.0 5.1 Raman CS, Li H, Martasek P, Kral V, Masters BS, Poulos TL. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell. 1998 Dec 23;95(7):939-50. PMID:9875848
- ↑ 6.0 6.1 6.2 Wei CC, Wang ZQ, Meade AL, McDonald JF, Stuehr DJ. Why do nitric oxide synthases use tetrahydrobiopterin? J Inorg Biochem. 2002 Sep 20;91(4):618-24. PMID:12237227
- ↑ Li H, Igarashi J, Jamal J, Yang W, Poulos TL. Structural studies of constitutive nitric oxide synthases with diatomic ligands bound. J Biol Inorg Chem. 2006 Sep;11(6):753-68. Epub 2006 Jun 28. PMID:16804678 doi:http://dx.doi.org/10.1007/s00775-006-0123-8
- ↑ 8.0 8.1 Fischmann TO, Hruza A, Niu XD, Fossetta JD, Lunn CA, Dolphin E, Prongay AJ, Reichert P, Lundell DJ, Narula SK, Weber PC. Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nat Struct Biol. 1999 Mar;6(3):233-42. PMID:10074942 doi:http://dx.doi.org/10.1038/6675
- ↑ Crane BR, Rosenfeld RJ, Arvai AS, Ghosh DK, Ghosh S, Tainer JA, Stuehr DJ, Getzoff ED. N-terminal domain swapping and metal ion binding in nitric oxide synthase dimerization. EMBO J. 1999 Nov 15;18(22):6271-81. PMID:10562539 doi:http://dx.doi.org/10.1093/emboj/18.22.6271
- ↑ Garcin ED, Bruns CM, Lloyd SJ, Hosfield DJ, Tiso M, Gachhui R, Stuehr DJ, Tainer JA, Getzoff ED. Structural basis for isozyme-specific regulation of electron transfer in nitric-oxide synthase. J Biol Chem. 2004 Sep 3;279(36):37918-27. Epub 2004 Jun 17. PMID:15208315 doi:http://dx.doi.org/10.1074/jbc.M406204200
Proteopedia Page Contributors and Editors (what is this?)
Sara Toftegaard Petersen, Michal Harel, Mathilde Thomsen, Michael Skovbo Windahl, Alexander Berchansky, Mette Trauelsen, Ann Taylor, Jaime Prilusky, Eran Hodis, Karl Oberholser